Clinical Indications

 Soft Tissue Tumors-Rhabdomyosarcoma

  •  4.5 case per 1 million children/adolescents

  • ~250 new cases in the United States each year

  • Most common soft-tissue sarcoma in children

  • 3rd most common solid tumor in children

  • VAC regimen or IVA regimen, radiation, and current standard of care-surgery, chemotherapy

      possibly immunotherapy

  •  5-year survival rate-67% for children younger than 15 years